Vanda Pharmaceuticals Stock Forecast

Stock Price Forecast

The 3 analysts that cover Vanda Pharmaceuticals stock have a consensus rating of "Strong Buy" and an average price target of $15.33, which forecasts a 242.95% increase in the stock price over the next year. The lowest target is $13 and the highest is $20.

Price Target: $15.33 (+242.95%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$13	$15.33	$13	$20
Change	+190.83%	+242.95%	+190.83%	+347.43%

* Price targets were last updated on May 14, 2025.

Analyst Ratings

The average analyst rating for Vanda Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	1	1	1	1	1	1
Buy	1	1	1	1	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	3	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Olivia Brayer Cantor Fitzgerald	Cantor Fitzgerald	Buy Initiates $13	Buy	Initiates	$13	+190.83%	May 14, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+347.43%	May 7, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $20	Strong Buy	Reiterates	$20	+347.43%	Apr 1, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $18 → $20	Strong Buy	Maintains	$18 → $20	+347.43%	Feb 18, 2025
Raghuram Selvaraju HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $18	Strong Buy	Reiterates	$18	+302.68%	Feb 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

232.28M

from 198.77M

16.86%

from 198.77M

Revenue Next Year

324.68M

from 232.28M

39.78%

from 232.28M

EPS This Year

-1.52

from -0.33

EPS Next Year

-0.39

from -1.52

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	248.17M	268.68M	254.38M	192.64M	198.77M	232.28M	324.68M	373.93M
Revenue Growth	9.24%	8.27%	-5.32%	-24.27%	3.18%	16.86%	39.78%	15.17%
EPS	0.42	0.58	0.11	0.04	-0.33	-1.52	-0.39	-0.03
EPS Growth	-80.10%	38.10%	-81.03%	-63.64%	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	5	5	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	239.5M	365.9M	384.9M
Avg	232.3M	324.7M	373.9M
Low	222.5M	280.8M	359.3M

Revenue Growth

Revenue Growth	2025	2026	2027
High	20.5%	57.5%	18.6%
Avg	16.9%	39.8%	15.2%
Low	11.9%	20.9%	10.7%

EPS Forecast

EPS	2025	2026	2027
High	-1.45	0.07	-0.03
Avg	-1.52	-0.39	-0.03
Low	-1.52	-1.23	-0.03

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.